Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic markerMasashi Takawa, Ryuji Hamamoto, Yuka Yamane et al.|Cancer Science|2011Cited by 191
Minichromosome Maintenance Protein 7 is a potential therapeutic target in human cancer and a novel prognostic marker of non-small cell lung cancerGouji Toyokawa, Ryuji Hamamoto, Ken Masuda et al.|Molecular Cancer|2011Cited by 113
Histone Lysine Methyltransferase Wolf-Hirschhorn Syndrome Candidate 1 Is Involved in Human Carcinogenesis through Regulation of the Wnt PathwayGouji Toyokawa, Ryuji Hamamoto, Hyun‐Soo Cho et al.|Neoplasia|2011Cited by 99
Deregulation of the histone demethylase JMJD2A is involved in human carcinogenesis through regulation of the G1/S transitionMasaharu Kogure, Ryuji Hamamoto, Masashi Takawa et al.|Cancer Letters|2013Cited by 69